The Medicare Access and CHIP Reauthorization Act: Implications for Nephrology

Area of Science:

• Health Policy
• Healthcare Economics
• Nephrology

Background:

• Rising Medicare costs prompted the Medicare Access and Children's Health Insurance Program Reauthorization Act of 2015.
• This legislation introduces a fundamental shift towards a pay-for-performance reimbursement system for healthcare providers.
• Provider performance will be assessed based on quality metrics starting in 2017, with cost considerations to be added in subsequent years.

Purpose of the Study:

• To highlight the implications of the Medicare Access and Children's Health Insurance Program Reauthorization Act for healthcare providers.
• To identify opportunities for nephrology providers in managing patient transitions from chronic kidney disease (CKD) to end-stage renal disease (ESRD).
• To emphasize the need for cost-efficient care models during patient transitions to ensure Medicare solvency.

Main Methods:

• The Centers for Medicare and Medicaid Services will evaluate provider costs using "episodes of care" and alternative payment models.
• Dialysis-specific alternative payment models have been implemented.
• Current models require development to encompass the CKD to ESRD patient transition phase.

Main Results:

• High-quality, cost-efficient providers will be incentivized with reimbursement bonuses.
• Low-quality, high-cost providers will face financial penalties.
• The development of effective patient transition protocols is crucial for value-based care.

Conclusions:

• Nephrology providers have a significant opportunity to develop innovative, cost-efficient care strategies for patients transitioning from CKD to ESRD.
• Successful implementation of these strategies can contribute to the long-term financial stability of the Medicare program.
• Adapting to pay-for-performance models is essential for providers to succeed under the new healthcare reimbursement landscape.